FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to obstetrics and gynaecology, and concerns cervical examination. Uterine cervix is examined in mirrors during colposcopy, cytological examination with verification of diagnosis, PCR examination of cervical epithelium scraping for HPV. Then performing targeted monomultifocal biopsy with primary detection of H-SIL; or primary surgical biopsy in L-SIL, benign hyperplastic processes, recurrent ASC-US. Thereafter, the obtained material is subjected to histological and immunohistochemical analysis using antibodies to p16INK4a and KI-67 proteins to assess the degree of manifestation of proliferative activity, as well as cell atypia. Homogenates are obtained from the obtained biopsy or surgical material by separating a fragment with a diameter of at least 5 mm with the inclusion of an endocervical zone, which is placed in a sterile test tube with addition of 5 ml of physiological solution. Then, during first 2-4 hours from the preparation of the material in the same test tube, it is homogenised with a rotary homogeniser to a homogeneous mass suspended in physiological solution, followed by centrifugation for 15 minutes at 3,000 rpm, then the supernatant in volume of 1 ml is placed into an Eppendorph test tube with a transport medium for collecting and transporting scrapings or smears of epithelial cells, then cervical tissue homogenates with predominance of glandular component are examined by PCR with determination of HPV 14 oncoserotypes with determination of viral load.
EFFECT: invention provides more effective diagnosis of cervical pathologies by assessing the degree of involvement of the cervix and especially cervical crypts in the pathological process.
1 cl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTING THE RISK OF RECURRENCE IN HPV16-POSITIVE PATIENTS WITH SQUAMOUS INTRAEPITHELIAL HIGH-GRADE DISEASE ON THE BASIS OF DETERMINING THE PHYSICAL STATUS OF THE VIRUS | 2019 |
|
RU2719581C1 |
DIAGNOSTIC TECHNIQUE OF CERVICAL INTRAEPITHELIAL NEOPLASIA | 2019 |
|
RU2705816C1 |
METHOD FOR PREVENTING PRECANCER RECURRENCE AND PRIMARY CERVICAL CANCER FOLLOWING ORGAN-PRESERVING TREATMENT BY DIAGNOSING AND TREATING HPV IN ANOGENITAL-OROPHARYNGEAL SPHERE IN SEXUAL PAIRS | 2020 |
|
RU2733934C2 |
METHOD FOR PREDICTING THE EFFECTIVENESS OF THE CONDUCTED TREATMENT OF I-II DEGREE CERVICAL INTRAEPITHELIAL NEOPLASIAS | 2021 |
|
RU2773799C1 |
METHOD FOR PREDICTION OF PROGRESSION OF LOW-GRADE CERVICAL SQUAMOUS INTRAEPITHELIAL LESION WITH UNDERLYING HUMAN PAPILLOMAVIRUS INFECTION | 2021 |
|
RU2766719C1 |
METHOD FOR MULTICOLORED IMMUNE-CYTOCHEMICAL DIAGNOSTICS OF PARANEOPLASIA OF CERVIX UTERI | 2020 |
|
RU2753236C1 |
METHOD FOR ASSESSING CONDITIONS OF PROLIFERATIVE CERVICAL DISEASES | 2012 |
|
RU2503960C1 |
METHOD OF PREDICTING PROGRESSION OF MILD INTRAEPITHELIAL NEOPLASIA IN WOMEN OF YOUNG AND FIRST PERIOD OF MATURE AGE | 2014 |
|
RU2572340C1 |
METHOD FOR PREDICTION OF PERSISTENCE OF ONCOGENIC HUMAN PAPILLOMA VIRUS IN CERVICAL EPITHELIUM | 2012 |
|
RU2520710C1 |
METHOD OF TREATING CERVICITIS ASSOCIATED WITH HUMAN PAPILLOMA VIRUS | 2018 |
|
RU2688326C1 |
Authors
Dates
2025-01-14—Published
2023-12-14—Filed